The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans

OBJECTIVE: Fructose consumption has been implicated in the development of obesity and insulin resistance. Emerging evidence shows that fibroblast growth factor 21 (FGF21) has beneficial effects on glucose, lipid, and energy metabolism and may also mediate an adaptive response to fructose ingestion....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Metab
Autores principales: ter Horst, Kasper W., Gilijamse, Pim W., Demirkiran, Ahmet, van Wagensveld, Bart A., Ackermans, Mariette T., Verheij, Joanne, Romijn, Johannes A., Nieuwdorp, Max, Maratos-Flier, Eleftheria, Herman, Mark A., Serlie, Mireille J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681276/
https://ncbi.nlm.nih.gov/pubmed/29107295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2017.08.014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares